Evidence map›Paper›PMID 34287371›Full record

ArticleMethods and protocols2021

Perilla Oil and

Yohei Sasaki, Mina Honyashiki, Takayuki Kinoshita, Akira Matsui, Ayako Nakashoji, Takuma Inagawa, Satoru Ikezawa, Naoki Yoshimura, Ryodai Yamamura, Mizuki Amano and 4 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Methods and protocols, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 5 institutions in 1 country.

Yohei SasakiDepartment of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Mina HonyashikiDepartment of Psychiatry, Tokyo Medical University, Tokyo 113-8510, Japan.
Takayuki KinoshitaDepartment of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo 187-8551, Japan.
Akira MatsuiDepartment of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo 187-8551, Japan.
Ayako NakashojiDepartment of Breast Surgery, National Hospital Organization Tokyo Medical Center, Tokyo 187-8551, Japan.
Takuma InagawaDepartment of Psychiatry, National Center Hospital of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Satoru IkezawaDepartment of Psychiatry, National Center Hospital of Neurology and Psychiatry, Tokyo 187-8551, Japan.ORCID 0000-0003-4712-9373
Naoki YoshimuraDepartment of Psychiatry, National Center Hospital of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Ryodai YamamuraDivision of Biomedical Oncology, Institute for Genetic Medicine, Hokkaido University, Sapporo 060-0815, Japan.
Mizuki AmanoToyosato Hospital, Ibaraki 529-1168, Japan.
Yui TomoDepartment of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Hisateru TachimoriDepartment of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.
Yutaka J MatsuokaDivision of Health Care Research, Center for Public Health Sciences, National Cancer Center Japan, Tokyo 104-0045, Japan.ORCID 0000-0002-8690-8129
Ryo OkuboDepartment of Clinical Epidemiology, Translational Medical Center, National Center of Neurology and Psychiatry, Tokyo 187-8551, Japan.ORCID 0000-0002-1254-1926
National Center of Neurology and Psychiatry · JPTokyo Medical Center · JPHokkaido University · JPJikei University School of Medicine · JPTokyo Medical University · JP

Funding

the Japan Society for Lipid Nutrition 2019 Ota Oil Promotion Awardthe Japan Society for the Promotion of Science 19K20171
6 · The paper itself

Abstract

The fear of cancer recurrence (FCR) is the most common and most severe unmet need among cancer survivors. Safe treatments for the FCR that are easily disseminated are greatly needed. Our primary aim is a preliminary evaluation of the efficacy and effect size of perilla oil, which is rich in omega-3 fatty acids, and

Indexed as

breast cancerfear of cancer recurrencemicrobiomeomega-3 fatty acidsprobiotics

Identifiers

PMID34287371
PMCPMC8293445
OpenAlexW3181391120

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.